Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
- 7 September 2006
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 109 (1), 139-144
- https://doi.org/10.1182/blood-2006-04-014654
Abstract
The Vitamins and Thrombosis (VITRO) study investigated the effect of homocysteine lowering by daily supplementation of B vitamins on the risk reduction of deep vein thrombosis (DVT) and pulmonary embolism (PE). Patients between 20 to 80 years old with a first objectively confirmed proximal DVT or PE in the absence of major risk factors and a homocysteine concentration above the 75th percentile of a reference group were asked to participate (hyperhomocysteinemic group). A similar study was conducted in a random sample of patients with a homocysteine below the 75th percentile of the reference group (normohomocysteinemic group). After informed consent was obtained, patients were randomized to daily multivitamin supplementation (5 mg folic acid, 50 mg pyridoxine, and 0.4 mg cyanocobalamin) or placebo and were followed for 2.5 years. End points were objectively diagnosed recurrent DVT or PE. A total of 701 patients were enrolled (360 in the hyperhomocysteinemic and 341 in the normohomocysteinemic group). The number of recurrent events of venous thrombosis was 43 of 353 in the vitamin group (54/1000 py) and 50 of 348 in the placebo group (64/1000 py). The hazard ratio associated with vitamin treatment was 0.84 (95% CI, 0.56-1.26): 1.14 (95% CI, 0.65-1.98) in the hyperhomocysteinemic group and 0.58 (95% CI, 0.31-1.07) in the normohomocysteinemic group. The results of our study do not show that homocysteine lowering by B vitamin supplementation prevents recurrent venous thrombosis. This trial was registered at www.clinicaltrials.gov as #NCT00314990.Keywords
This publication has 15 references indexed in Scilit:
- Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studiesJournal of Thrombosis and Haemostasis, 2005
- The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First EventArchives of Internal Medicine, 2003
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ, 2002
- MTHFR 677C→T Polymorphism and Risk of Coronary Heart DiseaseJAMA, 2002
- The homocysteine distribution: (Mis)judging the burdenJournal of Clinical Epidemiology, 2001
- Homocysteine and Venous Thrombosis: Outline of a Vitamin Intervention TrialSeminars in Thrombosis and Hemostasis, 2000
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trialsBMJ, 1998
- Vitamin Supplementation Reduces Blood Homocysteine LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?The Lancet, 1995
- A simple ultrasound approach for detection of recurrent proximal-vein thrombosis.Circulation, 1993